Search

Author/Creator Saad, Fred

1. 150: Impact of Clinical Trial Participation on Biochemical Recurrence in Prostate Cancer Patients Treated with External Beam Radiation Therapy. (September 2022)

Authors:
Lavigne, Danny; Flammia, Rocco Simone; Hoeh, Benedikt; Tian, Zhe; Saad, Fred; Anceschi, Umberto; Gallucci, Michele; Preisser, Felix; Mandel, Philipp; Chun, Felix K.H.; Karakiewicz, Pierre I.; Delouya, Guila; Taussky, Daniel
Journal:
Radiotherapy and oncology
Issue:
Volume 174(2022)Supplement 1
Page Start:
S63
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 161 PSMA-PET Guided Intensification of Radiotherapy for Prostate Cancer: Preliminary Detection Rate and Impact on Radiotherapeutic Management. (October 2019)

Authors:
Ménard, Cynthia; Delouya, Guila; Wong, Philip; Beauchemin, Marie-Claude; Barkati, Maroie; Taussky, Daniel; Bahary, Jean-Paul; Schuster, Tibor; Roberge, David; DaSilva, Jean; Juneau, Daniel; Saad, Fred
Journal:
Radiotherapy and oncology
Issue:
Volume 139(2019)Supplement 1
Page Start:
S69
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 174: Influence of Palliative Radiotherapy on Toxicity and Survival in Patients Treated with Radium-223 Dichloride for Metastatic Castrate-Resistant Prostate Cancer. (September 2022)

Authors:
Charrois-Durand, Cédric; Delouya, Guila; Taussky, Daniel; Barkati, Maroie; Saad, Fred; Lattouf, Jean-Baptiste; Perrotte, Paul; Karakiewicz, Pierre; Soulières, Denis; Blais, Normand; Hamilou, Zineb; Juneau, Daniel; Plouznikoff, Nicolas
Journal:
Radiotherapy and oncology
Issue:
Volume 174(2022)Supplement 1
Page Start:
S72
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 46: PSMA-PET/CT Guided Intensification of Radiotherapy for Prostate Cancer (PSMAGRT): Findings of Detection Rate, Impact on Cancer Management, and Early Toxicity from a Phase 2 Randomized Controlled Trial. (September 2022)

Authors:
Petit, Claire; Delouya, Guila; Taussky, Daniel; Barkati, Maroie; Lambert, Carole; Beauchemin, Marie-Claude; Clavel, Sébastien; Mok, Gary; Paré, Anne-Sophie Gauthier; Nguyen, Thu-van; Duplan, Danny; Keu, Khun Visith; Saad, Fred; Juneau, Daniel; Ménard, Cynthia
Journal:
Radiotherapy and oncology
Issue:
Volume 174(2022)Supplement 1
Page Start:
S22
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Issue 2 (February 2015)

Authors:
Ryan, Charles J; Smith, Matthew R; Fizazi, Karim; Saad, Fred; Mulders, Peter F A; Sternberg, Cora N; Miller, Kurt; Logothetis, Christopher J; Shore, Neal D; Small, Eric J; Carles, Joan; Flaig, Thomas W; Taplin, Mary-Ellen; Higano, Celestia S; de Souza, Paul; de Bono, Johann S; Griffin, Thomas W; ...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Issue 2 (February 2015)

Authors:
Ryan, Charles J; Smith, Matthew R; Fizazi, Karim; Saad, Fred; Mulders, Peter F A; Sternberg, Cora N; Miller, Kurt; Logothetis, Christopher J; Shore, Neal D; Small, Eric J; Carles, Joan; Flaig, Thomas W; Taplin, Mary-Ellen; Higano, Celestia S; de Souza, Paul; de Bono, Johann S; Griffin, Thomas W; ...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗